Together, these results suggest that the described amino acid substitutions are not all neutral and they have a functional effect, evidencing a marked inter- and intra-strain variability that can be relevant to determine the differences in GSH production
This finding aligns with an elevated -6/-3 PUFA ratio in heart tissues and indicates that targeting disturbances in glycerophospholipid and fatty acid metabolism in cancer cachexia hearts may be helpful

CLASSIFICATION: GROWTH HORMONE RELEASING PEPTIDE (GHRP) ACTIVE SUBSTANCE: SERMORELIN FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: 10 TO 20 MINUTES DOSAGE: MEN 100-300 MCG/DAY ACNE: RARE WATER RETENTION: NO HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA CLASSIFICATION: MITOCHONDRIAL-DERIVED PEPTIDE ACTIVE SUBSTANCE: MOTS-C FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: ~ 3-4 HOURS DOSAGE: 5-10 MG/WEEK (SPLIT INJECTIONS) ACNE: NO WATER RETENTION: NO HIGH BLOOD PRESSURE (HBP): NO IMPACT HEPATOTOXICITY: NONE AROMATIZATION: DOES NOT AROMATIZE MANUFACTURER: DRAGON PHARMA CLASSIFICATION: GROWTH FACTOR PEPTIDE ACTIVE SUBSTANCE: INSULIN-LIKE GROWTH FACTOR 1 LR3 FORM: 2 ML VIAL x 1 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: ~ 2030 HOURS DOSAGE: 20100 MCG PER DAY ACNE: NOT REPORTED WATER RETENTION: LOW HIGH BLOOD PRESSURE (HBP): NO KNOWN EFFECT HEPATOTOXICITY: NONE AROMATIZATION: DOES NOT AROMATIZE MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: GROWTH HORMONE RELEASING HORMONE ACTIVE SUBSTANCE: CJC-1295 DAC FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: ~ 6-8 days DOSAGE: 500 - 1000 MCG, 2-3X PER WEEK ACNE: RARE WATER RETENTION: MINIMAL HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NONE AROMATIZATION: NONE MANUFACTURER: DRAGON PHARMA CLASSIFICATION: GROWTH HORMONE RELEASING HORMONE (GHRH) ACTIVE SUBSTANCE: TESAMORELIN FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: 20 TO 30 MINUTES DOSAGE: MEN 1 TO 2 MG PER DAY ACNE: RARE WATER RETENTION: MINIMAL HIGH BLOOD PRESSURE (HBP): N/A HEPATOTOXICITY: NOT OBSERVED AROMATIZATION: NONE MANUFACTURER: DRAGON PHARMA

Ludmir EB, Sherry AD, Fellman BM, Liu S, Bathala T, Haymaker C, Medina-Rosales MN, Reuben A, Holliday EB, Smith GL, Noticewala SS, Nicholas S, Price TR, Martin-Paulpeter RM, Perles LA, Lee SS, Lee MS, Smaglo BG, Huey RW, Willis J, Zhao D, Cohen L, Taniguchi CM, Koay EJ, Katz MHG, Wolff RA, Das P, Pant S, Koong AC , Tang C
50 50
As a side note, he appears as a human kite from another world in Fractured But Hole